98 related articles for article (PubMed ID: 1914727)
1. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers.
Yamaguchi A; Kurosaka Y; Ishida T; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Miyazaki I
Dis Colon Rectum; 1991 Oct; 34(10):921-4. PubMed ID: 1914727
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery].
Sakurai Y; Kodaira S; Teramoto T; Sugano K; Abe O; Ohtake H; Iri H
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3205-12. PubMed ID: 2782914
[TBL] [Abstract][Full Text] [Related]
4. Serum and immunohistochemical studies of NCC-ST-439 in breast cancer.
Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
J Surg Oncol; 1993 Sep; 54(1):5-8. PubMed ID: 8377506
[TBL] [Abstract][Full Text] [Related]
5. [The expression of NCC-ST-439, a tumor marker, in human breast cancer patients].
Miyahara E; Toi M; Wada T; Yamada H; Osaki A; Yanagawa E; Toge T
Gan No Rinsho; 1990 Sep; 36(11):2023-6. PubMed ID: 2232168
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of NCC-ST-439 in Dukes' C colorectal cancer patients: a preliminary report.
Matsumoto K; Kinoshita T; Ishida T; Itoh H; Miki C; Suzuki H
Surg Today; 1999; 29(1):91-2. PubMed ID: 9934841
[TBL] [Abstract][Full Text] [Related]
7. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
Anzai K; Kurihara M; Izumi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma.
Iemura K; Moriya Y
Eur J Surg Oncol; 1993 Oct; 19(5):439-42. PubMed ID: 8405479
[TBL] [Abstract][Full Text] [Related]
10. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer.
Barillari P; Bolognese A; Chirletti P; Cardi M; Sammartino P; Stipa V
Dis Colon Rectum; 1992 May; 35(5):471-6. PubMed ID: 1568399
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
[TBL] [Abstract][Full Text] [Related]
12. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Carpelan-Holmström MA; Haglund CH; Roberts PJ
Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
[TBL] [Abstract][Full Text] [Related]
13. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
14. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity.
Engarås B
Dis Colon Rectum; 2003 Mar; 46(3):313-21. PubMed ID: 12626905
[TBL] [Abstract][Full Text] [Related]
15. Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: a prospective study.
Kurebayashi J; Nishimura R; Tanaka K; Kohno N; Kurosumi M; Moriya T; Ogawa Y; Taguchi T
Breast Cancer; 2004; 11(4):389-95. PubMed ID: 15604995
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibody NCC-ST-439 in gastric cancer tissue].
Kamata T; Yoneumura Y; Sugiyama K; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):222-7. PubMed ID: 2747606
[TBL] [Abstract][Full Text] [Related]
17. Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers.
Sugano K; Ohkura H; Maruyama T; Watanabe M; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Jpn J Cancer Res; 1988 May; 79(5):618-25. PubMed ID: 3136114
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
19. OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders.
Martell RE; Xu FJ; Davis WZ; Anselmino L; Yu YH; Daly L; Bast RC
Int J Biol Markers; 1998; 13(3):145-9. PubMed ID: 10079388
[TBL] [Abstract][Full Text] [Related]
20. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
Safi F; Kohler I; Röttinger E; Beger H
Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
